Analysis of drug transporter gene polymorphisms in an elderly patient with chronic myeloid leukemia successfully treated with intermittent low-dose dasatinib

Geriatr Gerontol Int. 2023 Dec;23(12):965-966. doi: 10.1111/ggi.14713. Epub 2023 Nov 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents* / therapeutic use
  • Chronic Disease
  • Dasatinib / therapeutic use
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Dasatinib
  • Protein Kinase Inhibitors
  • Antineoplastic Agents